Search
for
Sort by
Research 391–420 of 829
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms
- The Evidence for Microbes in the Small Intestine as the Mechanism for Post-Finasteride Syndrome: Self-Reported Case Study
- The Evidence for Microbes in the Small Intestine as the Mechanism for Post-Finasteride Syndrome: Self-Reported Case Study
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
- Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Xerostomia as a rare adverse effect of low-dose oral minoxidil: a case report with recurrence after re-challenge
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Larvicidal potential, antimicrobial properties and molecular docking analysis of Egyptian Mint (Mentha rotundifolia) against Culex pipiens L. (Diptera: Culicidae) and Midgut-borne Staphylococcus aureus
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- STUDY OF FECAL GLUCOCORTICOID METABOLITE IN BEARS: A REVIEW
- Greasy hair against obesity
- An unusual case of Cheyletiellosis in a Persian cat and its therapeutic management
- Compound Heterozygous Mutations in <i>Forkhead Box N1</i> (<i>FOXN1</i>) Lead to a Severe Immunodeficiency but Normal Hair and Nail Development in Patients
- EVALUATION OF GUT MICROBIOTA IN MELANOMA AND VITILIGO PATIENTS
- [Skin manifestations in patients with renal chronic renal failure on regular hemodyalysis].
- Sexual Adverse Effects of Finasterid 1mg for Treatment of Androgenic Alopecia in Men
- The Rotterdam Study: objectives and design update